# Systemic Lupus Erythematosus (SLE) Prospective Observational Cohort Study (SPOCS)

> **NCT03189875** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 830 (actual)

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

- **OTHER:** Standard of Care

## Key facts

- **NCT ID:** NCT03189875
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-28
- **Primary completion:** 2022-11-18
- **Final completion:** 2022-11-18
- **Target enrollment:** 830 (ACTUAL)
- **Last updated:** 2024-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03189875

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03189875, "Systemic Lupus Erythematosus (SLE) Prospective Observational Cohort Study (SPOCS)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03189875. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*